Serious adverse event
In drug development, serious adverse event (SAE) is defined as any untoward medical occurrence during a human drug trial that at any dose
- Results in death
- Is life-threatening
- Results in hospitalization or prolongs existing hospitalization
- Results in persistent or significant disability or incapacity
- May have caused a congenital anomaly or birth defect
- Requires intervention to prevent permanent impairment or damage
Here, "life-threatening" means that the patient was at risk of death at the time of the event; it does not apply to an event that hypothetically might have caused death if it were more severe. Adverse events are more broadly defined by international regulation as "Any untoward medical occurrence in a patient or clinical investigation subject administered a pharmaceutical product and which does not necessarily have to have a causal relationship with this treatment".